OMC
IDYA icon

Old Mission Capital’s IDEAYA Biosciences IDYA Stock Holding History

Old Mission Capital’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,146
Closed -$263K – 1471
2021
Q4 		$263K Buy
+11,146
New +$259K 0.01% 784

Other funds holding IDYA

LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Old Mission Capital's IDYA Position: Q1 2022 in Review

Old Mission Capital sold out of IDEAYA Biosciences (IDYA) in Q1 2022, closing a stake of 11,146 shares — an estimated $263K sold.

Old Mission Capital first reported a position in IDYA in Q4 2021 and held it in 1 quarter. The position peaked at $263K in Q4 2021. 103 funds tracked by Wall St. Rank hold IDYA as of Q1 2022.

  • Old Mission Capital reported no remaining IDEAYA Biosciences position as of Q1 2022 after selling out during the quarter.
  • Old Mission Capital sold 11,146 IDEAYA Biosciences shares in Q1 2022, an estimated $263K.
  • Old Mission Capital first reported a position in IDEAYA Biosciences in Q4 2021 and held it in 1 quarter.
  • Old Mission Capital's IDEAYA Biosciences position peaked at $263K in Q4 2021.
  • 103 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2022.

Based on Old Mission Capital's 13F filing for Q1 2022, filed 13 May 2022.